SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001485003-22-000156
Filing Date
2022-11-07
Accepted
2022-11-07 08:02:02
Documents
85
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q sesn-20220930.htm   iXBRL 10-Q 1580369
2 EX-31.1 sesn-09302022x10qex311.htm EX-31.1 11880
3 EX-31.2 sesn-09302022x10qex312.htm EX-31.2 11780
4 EX-32.1 sesn-09302022x10qex321.htm EX-32.1 6367
5 EX-32.2 sesn09302022-10qex322.htm EX-32.2 6341
  Complete submission text file 0001485003-22-000156.txt   7498642

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sesn-20220930.xsd EX-101.SCH 57289
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sesn-20220930_cal.xml EX-101.CAL 57271
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sesn-20220930_def.xml EX-101.DEF 280271
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sesn-20220930_lab.xml EX-101.LAB 660742
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sesn-20220930_pre.xml EX-101.PRE 449703
79 EXTRACTED XBRL INSTANCE DOCUMENT sesn-20220930_htm.xml XML 1148006
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36296 | Film No.: 221363784
SIC: 2834 Pharmaceutical Preparations